Clinical Trials
- Breast Cancer
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
- Child Development & Autism, Mental Health & Behavioral Research
123-MOMS: Pregnant women in their second trimester who plan on delivering at Yale New Haven Hospital
4202-HEM-301: An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE/HIBISCUS)
- Child Development & Autism
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
- Ages15 years - 45 years
- GenderBoth
- Liver
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
- Ages18 years and older
- GenderBoth
- Lung Cancer
A Biomarker-directed Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy
A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage
- Digestive System, Endocrine System
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
- Ages18 years - 85 years
- GenderBoth
- Phase 1 Cancers
A First-in-human, Phase 1 Study to Evaluate the Safety of TTX-080, an HLA-G Antagonist, in Subjects With Advanced Solid Tumors
- Phase 1 Cancers
A First-In-Human, Phase 1/2 Study Of CFI-402411, a Hematopoietic Progenitor Kinase-1 (HPK1) Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies